Gilead wins US nod for Bixlenvo, a new HIV combo for patients with suppressed viral load
|
The FDA has approved Bixlenvo, a new combination drug from
Gilead Sciences, for treating HIV in adults. The drug is for people
with suppressed ... |
New HIV infections in Canada are rising. Advocates say years of progress are at risk
The usual content of an HIV testing home kit displayed neatly on a table. New federal data shows HIV cases in Canada rose 23 per cent in 2024 compared ... View article...